Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer


VOLKAN M. , GÜRAY N. T. , Asik E., Lopez-Berestein G., Ozpolat B., Kahraman N.

AACR, 1 - 05 Nisan 2017, cilt.77, ss.1125 identifier